BioCrossroads

Report: Indiana boasts four nation-leading life sciences clusters

June 30, 2014
J.K. Wall
The areas around each of Indiana’s research university campuses—Bloomington, Indianapolis, Lafayette and South Bend—all boast outsize concentration of life sciences workers. Yet the state still lags on research, development and investment funding.
More

Algaeon to take big step after landing $2.75M

May 12, 2014
Dan Human
An Indianapolis-based biotech company plans to use $2.75 million in new funding to begin commercial production of its algae-based nutritional supplements, the firm announced Monday.
More

Life sciences critical mass elusive in Indiana after years of effortRestricted Content

May 10, 2014
J.K. Wall
Attempts to build the sector are making headway, but Indiana still lags leading states.
More

Lilly Endowment to give $10M to start biosciences institute

June 27, 2013
J.K. Wall
The institute aims to attract 100 new scientists to Indiana to conduct research and development work aimed at launching new therapies for metabolic diseases.
More

Research institute tries to succeed where Michigan failed

June 3, 2013
J.K. Wall
While Indiana’s governor, legislature and life sciences executives are united behind the proposed Indiana Biosciences Research Institute, the state of Michigan has a cautionary tale to tell about such an effort.
More

New institute aims to attract 100 research scientists to Indiana

May 30, 2013
J.K. Wall
The $360 million initiative will be formally launched on Thursday by Gov. Mike Pence, executives of five major life sciences companies and officials of the state’s research universities.
More

Mobile health apps could cut into state companies' market share

May 18, 2013
J.K. Wall
The future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source: smartphone apps.
More

PANEL: Life sciences will see radically different futureRestricted Content

May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues of venture capital, digital health innovations and research university entrepreneurship.

Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president, CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy, PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.

The following is an unedited transcript of the discussion.

More

Indiana officials look to boost agriculture research

February 3, 2013
Associated Press
The state's agriculture department under new Gov. Mike Pence is planning a push into the science behind food production by trying to build a network of university and commercial researchers for what's being called an Agriculture Innovation Corridor.
More

Health care startups hungry for fundsRestricted Content

February 2, 2013
J.K. Wall
Frustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create a dedicated funding stream that could total $30 million a year.
More

BioCrossroads: Life sciences a $50B industry in Indiana

January 22, 2013
J.K. Wall
The life sciences industry in Indiana employs 55,500 workers paying average wages of more than $88,500 per year, according to new figures released Tuesday by Indianapolis-based life sciences development group BioCrossroads.
More

BioCrossroads seed fund makes first investments

January 10, 2013
Local startups Esanex Inc. and Algaeon Inc. have received $500,000 and $250,000, respectively, from Indiana Seed Fund II, BioCrossroads' second fund to help fledgling life sciences companies.
More

Johnson picked to succeed Miles as leader of CICP

December 18, 2012
 IBJ Staff
BioCrossroads CEO David Johnson has been chosen president and CEO of the Central Indiana Corporate Partnership, succeeding Mark Miles, who is leaving the CICP after seven years to become CEO of Hulman & Co.
More

Life sciences leader juggles faith, science and businessRestricted Content

November 3, 2012
J.K. Wall
BioCrossroads CEO David Johnson sees little conflict as he balances all three in promoting and investing in Indiana life sciences firms
More

Outlook gloomy for device investments

October 29, 2012
J.K. Wall
The amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association and PricewaterhouseCoopers.
More

Lilly CEO calls for life sciences research institute

October 23, 2012
J.K. Wall
Eli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.
More

Next up for Indiana biotech: Feed the world

August 6, 2012
J.K. Wall
Even though the potential payoff for health care innovation is less certain these days, the business case for new ways to produce more food has never been stronger. That’s the analysis that lies behind BioCrossroads' new report an agricultural innovation.
More

Indiana life sciences companies rethink innovationRestricted Content

July 28, 2012
J.K. Wall
Research and development comes under pressure in an age of austerity.
More

Life sciences hold up in recession

June 25, 2012
J.K. Wall
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
More

BioCrossroads launches second seed fund

April 30, 2012
J.K. Wall
BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow to the point where they can attract venture capital or a corporate funder.
More

BioCrossroads has stoked state's life sciences industry, but challenges remainRestricted Content

February 11, 2012
J.K. Wall
In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.
More

Health care VC hits new Indiana low in 2011

February 6, 2012
J.K. Wall
Indiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to  the state’s health care sector since BioEnterprises began tracking such deals in 2005.
More

Indiana's medical device workforce will need skills upgradeRestricted Content

January 14, 2012
J.K. Wall
A new report by BioCrossroads says 53 percent of the 20,000 jobs in Indiana’s medical-device sector require no more than a high school education.
More

BioCrossroads seeds upstart medical device maker

October 20, 2011
Chris O'Malley
BioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive developing an absorbable stent.
More

Biocrossroads lands $2.8 million Lilly Endowment grantRestricted Content

October 8, 2011
 IBJ Staff
The advocate for the state's life sciences industry has now pulled in more than $25 million from the endowment.
More
Page  1 2 3 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT